Update on triple-negative breast cancer disparities for the United States: A population-based study from the United States Cancer Statistics database, 2010 through 2014
- PMID: 31282032
- PMCID: PMC6744285
- DOI: 10.1002/cncr.32207
Update on triple-negative breast cancer disparities for the United States: A population-based study from the United States Cancer Statistics database, 2010 through 2014
Abstract
Background: Triple-negative breast cancer (TNBC) has been associated with a more aggressive histology, poorer prognosis, and nonresponsiveness to hormone therapy. It is imperative that cancer research identify factors that drive disparities and focus on prevention.
Methods: Using the United States Cancer Statistics database, the authors examined differences between TNBCs compared with all other breast cancers with regard to age, race/ethnicity, and stage at diagnosis.
Results: A total of 1,151,724 cases of breast cancer were identified from 2010 through 2014, with the triple-negative phenotype accounting for approximately 8.4% of all cases. In unadjusted analyses, non-Hispanic black women (odds ratio [OR], 2.27; 95% CI, 2.23-2.31) and Hispanic women (OR, 1.22; 95% CI, 1.19-1.25) had higher odds of diagnosis when compared with non-Hispanic white women. Women aged <40 years had the highest odds of diagnosis compared with women aged 50 to 64 years (OR, 1.95; 95% CI, 1.90-2.01). Diagnosis at American Joint Committee on Cancer stage III and beyond conferred higher odds of the diagnosis of TNBC (OR for stage III, 1.69 [95% CI, 1.68-1.72]; and OR for stage IV, 1.47 [95% CI, 1.43-1.51]). Results varied slightly in adjusted analyses.
Conclusions: The results of the current study demonstrated that there is a significant burden of disease in TNBC diagnosed among women of color, specifically non-Hispanic black women, and younger women. Additional studies are needed to determine drivers of disparities between race, age, and stage of disease at diagnosis.
Keywords: continental population groups; epidemiology; ethnic groups; health status disparities; registries; triple-negative breast neoplasms.
© 2019 American Cancer Society.
Conflict of interest statement
References
-
- Bauer KR, Brown M, Cress RD, Parise CA, Caggiano V. Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer Registry. Cancer 2007;109(9):1721–1728. - PubMed
-
- Field TS, Buist DSM, Doubeni C, et al. Disparities and Survival Among Breast Cancer Patients. JNCI Monographs 2005;2005(35):88–95. - PubMed
-
- Chu KC, Lamar CA, Freeman HP. Racial disparities in breast carcinoma survival rates. Cancer 2003;97(11):2853–2860. - PubMed
-
- Newman LA. Breast cancer in African-American women. The oncologist 2005;10(1):1–14. - PubMed
-
- Noone A, Howlader N, Krapcho M, et al. SEER Cancer Statistics Review, 1975–2015 Bethesda, MD: National Cancer Institute; 2018. https://seer.cancer.gov/csr/1975_2015/. Published April 2018. Accessed May 2018.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
